HALO
Halozyme Therapeutics Inc
110.80$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.4% | +6.2% | +6.9% | +7.5% | -2.6% | +6.4% | -6.5% | +8.1% | +13.7% | +5.8% | -3.6% | |
| – | -15.1% | +17.0% | +13.1% | +14.1% | -3.7% | +16.3% | -11.0% | +18.4% | -37.9% | +21.5% | -7.0% | |
| – | -56.8% | +39.1% | +14.1% | -17.9% | -24.9% | +52.2% | -64.9% | +578.4% | -68.1% | +131.5% | -47.3% | |
| – | -30.5% | +37.9% | +14.2% | +25.9% | -10.5% | +25.5% | -26.7% | +28.1% | -79.7% | +123.1% | -27.5% | |
| – | +7.8% | -16.4% | +9.5% | +33.2% | +7.9% | -1.2% | +3.8% | +9.4% | +27.5% | +3.8% | -0.5% | |
| – | -1.0% | +32.1% | -5.5% | -17.5% | +8.0% | +16.2% | +10.1% | +2.4% | -5.0% | -11.9% | -11.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +39.2% | +0.3% | -0.1% | |
| – | -3.6% | -3.8% | -3.9% | -4.1% | -4.2% | -4.4% | -4.6% | -4.8% | +181.6% | -3.0% | -3.1% | |
| – | +0.4% | +0.9% | +1.0% | -0.9% | +2.1% | +0.9% | +0.4% | -0.2% | +44.2% | -0.9% | -0.8% | |
| – | -2.3% | +17.0% | +1.3% | -18.4% | +27.8% | +8.1% | -10.7% | +523.5% | -78.8% | +105.1% | -5.2% | |
| – | -0.5% | -1.3% | -3.5% | – | – | – | – | – | – | – | +0.1% | |
| – | -38.8% | +12.8% | +15.8% | -19.7% | -17.3% | +95.9% | -6.9% | -17.8% | +36.1% | -32.5% | +67.5% | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | -47.0% | +167.8% | -9.6% | +0.1% | |
| – | -66.4% | +112.2% | +62.8% | +56.4% | -19.6% | +32.6% | -31.0% | +51.4% | -90.3% | +349.9% | -34.6% | |
| – | -59.3% | +84.8% | +55.7% | +52.6% | -9.5% | +32.8% | -24.5% | +39.1% | -89.1% | +273.9% | -26.2% | |
| – | -2.3% | -1.6% | +0.3% | +0.7% | -0.5% | -2.1% | -2.0% | -1.5% | -3.8% | +4.4% | -1.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.